How much revenue does Novartis India make?

Novartis India reported 3.54 billion INR in revenue for fiscal year 2026, down 0.5% from 3.56 billion INR in fiscal year 2025.

What companies are similar to Novartis India?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sanofi India Limited (SANOFI.NS), Sun Pharma Advanced Research Company Limited (SPARC.NS), FDC Limited (FDC.NS), RPG Life Sciences Limited (RPGLIFE.NS).

Novartis India Limited (NOVARTIND.BO) Stock

About Novartis India Limited

Evonile Pharma Limited is involved in the pharmaceutical business in India and internationally. It operates Pharma International (Commercial operations), Development (Drug development), Biomedical Research, and Operations. The company offers therapeutic products in the areas of bone and pain under the Voveran brand; transplantation immunology under the Simulect, Certican, Sandimmun, Neoral, and My...

At a glance

Novartis India reported revenue of 3.54 billion INR for fiscal year 2026, down 0.5% from fiscal year 2025, and net income of 931.80 million INR.

Figures from company filings; latest fiscal year ended March 31, 2026.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.